Stereotactic Ablative Radiotherapy (SABR)

https://www.researchgate.net/figure/Stereotactic-ablative-radiotherapy-SABR-dose-distribution-and-post-treatment-tumor_fig1_330681561

A Brief History of SABR:

“Stereotactic ablative radiotherapy (SABR) refers to high precision radiotherapy with the aim of delivering an ablative dose of radiotherapy in fewer fractions with minimal dose to surrounding normal tissue.”

Stereotactic radiotherapy, originally piloted for treating tumors situated in important functional parts of the brain, operates on a converging-beam principle in which dozens of highly focused yet relatively weak radiation beams from different directions travel through normal tissues on their way to a tumor target deep within the body. The intentionally weak beams cause little entry damage, but at the point of convergence, they add up to deliver a very potent tumor treatment.”

Stages in the Development of SABR:

Pioneers in the Development of SABR:

REFERENCES:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163903/

https://www.utsouthwestern.edu/simmons/research/scientific-programs/experimental-therapeutics/sabr.html

https://www.researchgate.net/figure/Stereotactic-ablative-radiotherapy-SABR-dose-distribution-and-post-treatment-tumor_fig1_330681561

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316669/